PC
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PC, covering 2019-04-17 to 2022-05-27. Get the full timeline:
Most recent: Clinical Trial Update: Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC [Phase 2]